Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA vs Inhalational Anaesthesia in Modified Radical Mastectomy
NCT03807297Phase 2Completed
- Sponsor
- Rajiv Gandhi Cancer Institute and Research Centre
- Start
- Jan 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of propofol injection (veterinary) and dexmedetomidine in breast cancer (2 arms), sponsored by Rajiv Gandhi Cancer Institute and Research Centre. Primary endpoint: Feasibility of Total Intravenous Anesthesia at 3 hours. Started Jan 2019; status: completed.
02
Drugs
propofol injection (veterinary)dexmedetomidine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03807297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03807297.